Previous studies have shown that robust serological and mucosal IgA responses are associated with a better prognosis of flu disease and decreased influenza transmission (Clements et al., 1986; Belshe et al., 2000; Ambrose et al., 2012; Abreu et al., 2020). Here, CD79A is linked to influenza.